Literature DB >> 29985678

Lichen Planus in Ocular Surface: Major Presentations and Treatments.

Masoomeh Mohebbi1, Masoud Mirghorbani1, Ali Banafshe Afshan1, Mohsen Towfighi1.   

Abstract

Ocular lichen planus (LP) is a rare disease which has been increasingly reported in the literature in the last two decades involving conjunctiva, cornea, and lacrimal drainage system. Most reported cases of ocular LP are cicatricial conjunctivitis with subepithelial fibrosis, fornix shortening, and symblepharon formation. It is not clear whether corneal involvement is a primary event or secondary to these changes. Topical cyclosporine and corticosteroid can be considered as first-line therapy in ocular surface involvement, while treatment regimen in more aggravated disease should be boosted with systemic immunosuppressives. After resolving acute inflammation, the patient should be treated with long-term maintenance therapy to halt the chronic progression of the disease. Lacrimal drainage system could also be involved, usually in a bilateral bicanalicular pattern with severe punctal/canalicular stenosis. Because of severity, the surgical outcomes are not favorable but successive treatments with dacryocystorhinostomy + mitomycin C (MMC), Jones tube implantation, and systemic cyclosporine are reported.

Entities:  

Keywords:  Conjunctivitis; cyclosporine; keratitis; lacrimal drainage system; lichen planus

Year:  2018        PMID: 29985678     DOI: 10.1080/09273948.2018.1485955

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  2 in total

1.  Lichen planus and multifocal choroiditis - A diagnostic dilemma.

Authors:  Mayur R Moreker; Tanuj R Sharma; Vibhor P Pardasani
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

Review 2.  Special Care in Lichen Planus Patients Undergoing LASIK: A Review Article.

Authors:  Majid Moshirfar; Harry Y Liu; David B Rosen; Madeline B Heiland; Masoud Mirghorbani; Yasmyne C Ronquillo; Phillip C Hoopes
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.